Oracle [ORCL] - Last Close: $114.13
New earnings data is powering Oracle to the top of the S&P 500, after its report showed a sharp rebound from its cloud services unit.
Oracle generated a 25% jump in cloud revenue for its fiscal Q3, and the company’s bottom-line EPS exceeded the consensus.
ORCL is leading the S&P 500 with a 12.2% gain on more than 800K shares traded.
My Take: ORCL has struggled to keep pace with competitors in recent months, but this report could put them back on investors’ radar.
ClearOne [CLRO] - Last Close: $0.9053
After Monday’s close, this tiny videoconferencing hardware stock announced a special dividend of $0.50 per share.
The dividend totals more than 50% of the stock’s current share price, so the stock is seeing a big rally on the news.
CLRO is up 71.2% on more than 7.5 million shares traded.
My Take: CLRO will get a short-term boost from this news, but it will likely see a big drop once the ex-div date passes.
Regulus Therapeutics [RGLS] - Last Close: $1.38
Top-line data from a Phase 1b trial of RGLS8429 for autosomal dominant polycystic kidney disease is boosting shares of Regulus Therapeutics.
Regulus posted promising early data and said the study’s third cohort is fully enrolled with data expected in mid-2024.
The company also announced an oversubscribed $100 million private placement of equity.
RGLS is up 65.9% on roughly 12 million shares traded.
My Take:RGLS has been very volatile as of late, but this move is currently on pace to push the stock through a tough resistance point at $1.60 per share.
Assure Holdings [IONM] - Last Close: $0.3410
Yesterday evening, Assure announced a deal to sell its IONM business assets to MPOWERHealth for up to $4.5 million in cash.
The deal includes most of Assure’s health care facility contracts and clinical equipment, with $2.5 million paid at the initial closing.
The remaining $2 million will be a potential payment tied to case volume from the assets generated in the 12-month period following closing.
IONM is up 38.8% on more than 5 million shares traded.
My Take: IONM will get a short-term boost from this news, but I am not sure that it will be enough to change this company’s long-term outlook.